Security key
78397T202
SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)
CUSIP: 78397T202
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 1,923,874
- Total 13F value
- $3,369,565
- Share change
- -285,678
- SEC-reported price per share
- $1.76
- Number of holders
- 25
- Value change
- -$378,633
- Number of buys
- 9
- Number of sells
- 8
- Shares outstanding
- 76,568,369
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
25
Top holders
10
SABS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
SAB Biotherapeutics, Inc. SEC filings
SAB Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78397T202
Recent filing periods:
Ownership snapshot
Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
1.2%
Sessa Capital IM, L.P.
0.6%
VANGUARD GROUP INC
0.36%
GEODE CAPITAL MANAGEMENT, LLC
0.11%
Pathstone Holdings, LLC
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
1.2%
|
$1,239,065
917,826 shares
|
— | 31 Mar 2025 |
| Sessa Capital IM, L.P. |
13F
Company
|
0.6%
|
$623,502
458,457 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.36%
|
$374,639
277,510 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.11%
|
$114,342
84,685 shares
|
— | 31 Mar 2025 |
| Pathstone Holdings, LLC |
13F
Company
|
0.07%
|
$68,885
50,650 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
0.03%
|
$30,330
22,301 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
1,923,874
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
26
Q2 2025 holders
25
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend